UPDATE: Quoin Pharmaceuticals (QNRX) - The Clock Runs Faster Than the Catalysts

Q2 leaves $10.8M against an $8.0M half-year burn and an unchanged going-concern flag — while the one readout that actually matters, the placebo-controlled POC 1, went missing from the update entirely.